Exciting news for our New Zealand type 1 diabetes (T1D) & type 3c diabetes friends: continuous glucose monitors and insulin pumps have been funded from 1 October 2024 for eligible people. Congratulations to all the type 1 diabetes advocates and diabetes organisations who campaigned for this change, which will make a huge difference for the T1D community! #insulinpump #CGM #type1diabetes #T1D
JDRF Australia’s Post
More Relevant Posts
-
It's Type 2 Diabetes Prevention Week, and of course, Taiba Medserv never misses a chance to share the best insulin therapy option for managing blood sugar levels: Meet the MiniMed™ 780G by Medtronic Diabetes! It’s got Meal Detection technology that automatically delivers correction boluses every 5 minutes, no effort needed, because life with diabetes can be unpredictable. Don't let Diabetes hold you back! Making #healthcare accessible to all. #TaibaMedserv #DiabetesPreventionWeek #Type2Diabetes #InsulinTherapy #InsulinPen #InsulinPump #DiabetesAwareness #CGM #HealthManagement #BloodSugarControl #DiabetesCare #MiniMed780G
To view or add a comment, sign in
-
For people with type 2 diabetes not on insulin, CGMs are critical for improving clinical outcomes—but only a small percentage of people with type 2 diabetes are using CGM! You can learn how to help people with type 2 diabetes start thriving while using CGM and time in range at https://lnkd.in/eY3wjstR. #TimeInRange #CGM #DiabetesNews #T1D #T2D
To view or add a comment, sign in
-
At Ypsomed AG diabetes care, this is what we are striving for. Empowering people living with diabetes with mylife Loop. CamDiab #Ypsopump (2) NHS England on X: "Watch Ava-Rose show us her superpower! 🦸 She has an ‘artificial pancreas’ or hybrid closed loop technology (HCL) to manage her type 1 diabetes. HCL uses a continuous glucose monitor linked with an insulin pump to automatically adjust the amount of insulin she is given. https://t.co/cIRHloFI2R" / X (twitter.com)
To view or add a comment, sign in
-
ICYMI: Diabetes Mellitus is estimated to impact 400 million 👴🏽 👵people globally. ✅ Check out how PointClickCare can help you determine the impact GLP-1s are having on diabetes. #pointclickcare #data #lifescience
Are GLP-1s Treating Type 2 and Type 3 Diabetes? - PointClickCare
infl.tv
To view or add a comment, sign in
-
ICYMI: Diabetes Mellitus is estimated to impact 400 million 👴🏽 👵people globally. ✅ Check out how PointClickCare can help you determine the impact GLP-1s are having on diabetes. #pointclickcare #data #lifescience
Are GLP-1s Treating Type 2 and Type 3 Diabetes? - PointClickCare
infl.tv
To view or add a comment, sign in
-
ICYMI: Diabetes Mellitus is estimated to impact 400 million 👴🏽 👵people globally. ✅ Check out how PointClickCare can help you determine the impact GLP-1s are having on diabetes. #pointclickcare #data #lifescience
Are GLP-1s Treating Type 2 and Type 3 Diabetes? - PointClickCare
infl.tv
To view or add a comment, sign in
-
ICYMI: Diabetes Mellitus is estimated to impact 400 million 👴🏽 👵people globally. ✅ Check out how PointClickCare can help you determine the impact GLP-1s are having on diabetes. #pointclickcare #data #lifescience
Are GLP-1s Treating Type 2 and Type 3 Diabetes? - PointClickCare
infl.tv
To view or add a comment, sign in
-
ICYMI: Diabetes Mellitus is estimated to impact 400 million 👴🏽 👵people globally. ✅ Check out how PointClickCare can help you determine the impact GLP-1s are having on diabetes. #pointclickcare #data #lifescience
Are GLP-1s Treating Type 2 and Type 3 Diabetes? - PointClickCare
infl.tv
To view or add a comment, sign in
-
ICYMI: Diabetes Mellitus is estimated to impact 400 million 👴🏽 👵people globally. ✅ Check out how PointClickCare can help you determine the impact GLP-1s are having on diabetes. #pointclickcare #data #lifescience
Are GLP-1s Treating Type 2 and Type 3 Diabetes? - PointClickCare
infl.tv
To view or add a comment, sign in
-
ICYMI: Diabetes Mellitus is estimated to impact 400 million 👴🏽 👵people globally. ✅ Check out how PointClickCare can help you determine the impact GLP-1s are having on diabetes. #pointclickcare #data #lifescience
Are GLP-1s Treating Type 2 and Type 3 Diabetes? - PointClickCare
infl.tv
To view or add a comment, sign in
3,784 followers
More information about the announcement, available technology and eligibility here: https://pharmac.govt.nz/news-and-resources/news/pharmac-to-fund-continuous-glucose-monitors-for-thousands-of-people-with-type-1-diabetes